(Q39769632)

14 September 2017

1 reference

title

Clinical pharmacokinetics of digitalis glycosides (English)

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Cardiology and cardiovascular medicine

26 June 2022

main subject

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

26 June 2022

1 reference

J. E. Doherty

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356122

26 June 2022

N. de Soyza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356122

26 June 2022

J. J. Kane

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356122

26 June 2022

J. K. Bissett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356122

26 June 2022

M. L. Murphy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356122

26 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=356122

26 June 2022

publication date

1 September 1978

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:0033062078900208?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

https://api.elsevier.com/content/article/PII:0033062078900208?httpAccept=text/plain

26 June 2022

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Progress in Cardiovascular Diseases

26 June 2022

published in

1 reference

14 September 2017

volume

21

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

141-158

1 reference

Studies on the renal excretion of radioactive digitoxin in human subjects with cardiac failure

14 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Studies with radioactive digitalis

5 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug

5 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Tritiated digoxin studies in human subjects

5 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS

5 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay

5 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Digoxin-specific antibodies

5 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Determination of Therapeutic and Toxic Serum Digoxin Concentrations by Radioimmunoassay

5 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Contribution of quantitative assay technics to the understanding of the clinical pharmacology of digitalis

5 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Studies with tritiated digoxin in human subjects after intravenous administration

5 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Pain and CPX elevation after intramuscular digoxin

5 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

5 April 2023

Low-renin hypertension

18

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

STUDIES FOLLOWING INTRAMUSCULAR TRITIATED DIGOXIN IN HUMAN SUBJECTS

5 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Determinants of digitalis dosage

5 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Clinical Pharmacokinetics of Digoxin

5 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Variation in Biologic Availability of Digoxin from Four Preparations

5 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Tritiated digoxin. XV. Serum protein binding in human subjects

5 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Binding of digitoxin and some related cardenolides to human plasma proteins

5 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Studies on digitalis. V. The influence of impaired renal function, hemodialysis, and drug interaction on serum protein binding of digitoxin and digoxin

5 April 2023

25

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

The distribution and concentration of tritiated digoxin in human tissues

5 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Tritiated digoxin. XIV. Enterohepatic circulation, absorption, and excretion studies in human volunteers

5 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Tissue concentration and turnover of tritiated digoxin in dogs

5 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Correlation of serum concentrations with heart concentrations of digoxin in human subjects.

5 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Human serum and myocardium digoxin

5 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Blood level studies of C14-digitoxin in human subjects with cardiac failure

5 April 2023

31

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Double isotope dilution derivative assay of digitoxin in plasma, urine, and stool of patients maintained on the drug

5 April 2023

32

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Clinical pharmacokinetics of digitoxin

5 April 2023

35

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites

5 April 2023

37

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Biliary excretion of digoxin in man

5 April 2023

38

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay

5 April 2023

40

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Plasma and tissue digoxin concentrations in patients undergoing cardiopulmonary bypass

5 April 2023

41

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Myocardial and Skeletal Muscle Concentrations of Digoxin in Patients on Long-term Therapy

5 April 2023

42

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Relation between concentrations of digoxin in the myocardium and in the plasma

5 April 2023

43

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Digoxin Metabolism in the Elderly

5 April 2023

44

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE

5 April 2023

45

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Digitalis in Pulmonary Heart Disease (Cor Pulmonale)1

5 April 2023

47

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Digoxin metabolism in obesity

5 April 2023

48

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Localization of the renal excretion of the tritiated digoxin

5 April 2023

49

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Renal tubular secretion of digoxin

5 April 2023

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Determinants of the renal clearance of digoxin

5 April 2023

51

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Some aspects of the distribution and disposition of digitoxin in man

5 April 2023

52

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Disposition of digitoxin in renal failure

5 April 2023

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Studies on digitalis; II. The influence of impaired renal function on the renal excretion of digitoxin and its cardioactive metabolites

5 April 2023

55

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Studies with tritiated digoxin in anephric human subjects

5 April 2023

56

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Peritoneal Dialysis and Hemodialysis of Tritiated Digoxin

5 April 2023

57

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis

5 April 2023

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies

5 April 2023

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Electrocardiographic changes during hemodialysis with the artificial kidney. II. The treatment of digitalis intoxication

5 April 2023

61

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease.

5 April 2023

62

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Serum digoxin in patients with thyroid disease

5 April 2023

63

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Digoxin kinetics in patients with thyroid dysfunction

5 April 2023

64

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Digoxin in hyperthyroidism

5 April 2023

65

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Longterm electrocardiographic monitoring of ambulatory patients with chronic airway obstruction

5 April 2023

67

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Digitalis and experimental myocardial infarction

5 April 2023

68

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Altered Distribution of Tritiated Digoxin in the Infarcted Canine Left Ventricle

5 April 2023

69

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Tritiated digoxin. XX. Tissue distribution in experimental myocardial infarction

5 April 2023

70

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

5 April 2023

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure

5 April 2023

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Clinical Pharmacokinetics of Digoxin in Infants

5 April 2023

73

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Effect of cholestyramine on digoxin absorption and excretion in man

5 April 2023

75

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Decreased bioavailability of digoxin due to antacids and kaolin-pectin

5 April 2023

78

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Clinical pharmacology and therapeutics use of digitalis glycosides.

5 April 2023

80

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

New Information Regarding Digitalis Metabolism

5 April 2023

81

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Tritiated digoxin. XVII. Excretion and turnover times in normal donors before and after nephrectomy and in the paired recipient of the kidney after transplantation

5 April 2023

82

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Tritiated digoxin excretion of patients following renal transplantation

5 April 2023

83

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

Effect of quinidine on plasma concentrations of digoxin

5 April 2023

85

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90020-8

5 April 2023

Identifiers

1 reference

14 September 2017

1 reference